Work

Optimization of serum miR-371a-3p for the detection of chemotherapy-naïve minimal residual germ cell tumor.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.423

Authors: John T. Lafin, Armon Amini, Bendu Konneh, Anna Savelyeva, Jin Piao, Michelle Nuno, Cinzia Scarpini, Jeffrey Howard, Thomas Gerald, Liwei Jia, Nicholas Coleman, Matthew Murray, Lindsay Lindsay Frazier, James F. Amatruda, Aditya Bagrodia

Institutions: The University of Texas Southwestern Medical Center, Children's Oncology Group, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Dana-Farber Cancer Institute, Massachusetts General Hospital

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Prevention and Research Institute of Texas

OpenAlex ID: W4213035641

Cites:

Cited by:

Related to: 10